Generation change 4.0 at Ottobock

Duderstadt (Germany) September 15th (PROTEXT/ots)

German medtech company sets course for future

Prof. Hans Georg Näder’s youngest daughter, Georgia, will in future be representing the family on Ottobock’s supervisory board, which is currently being formed. Otto Bock HealthCare GmbH, based in the German state of Lower Saxony, is undergoing the conversion to an SE & Co. KGaA. Georgia Näder will therefore also be enlisted to the executive board of Otto Bock Holding GmbH & Co. KG.

Following nearly three decades in his role as CEO at Otto Bock HealthCare GmbH, Prof. Hans Georg Näder (56) will be assuming the leadership of the supervisory board of the future Ottobock SE & Co. KGaA as chairman of the board. Dr Oliver Scheel (49) will take over the role of CEO on 15 January 2018. The appointment of Dr Scheel, a long-time partner and managing director at consulting company A.T. Kearney and head of their pharma, medical technology and healthcare department who possesses extensive expertise in the subject of transformation management, represents the first time in Ottobock’s history that a manager from outside the family has taken the helm of the German-based “hidden champion” and global market leader in the field of technical orthopaedics.

Longstanding CFO Harry Wertz (60) will exclusively continue his role as CEO with the Otto Bock Holding GmbH & CoKG.

The head of the Näder Family Office, Stefan Hirsch (45), was also enlisted to the executive board of Otto Bock Holding GmbH & Co. KG as part of the developments within the company. Further information: http://www.ottobock.com/en/press/press-releases/news-overview-page-2.0.html

Head of Investor Relations / Corporate Communications

Mark C. Schneider

Phone: +49 (0) 30 398 206 222 / mobile: +49 (0) 151 146 591 35

Email: MarkC.Schneider@ottobock.de

 

SENDING PRESS RELEASES

I want to receive press releases with the same keywords as this article:

Keywords

Germany-health-pharmaceutical-medicines

Category

Health, medical treatment, pharmaceuticals

Region

Europe, EU, NATO

Photograph

 
 

Important notice

Subscribers please note that material bearing the label "PROTEXT" is not part of CTK's news service and is not to be published under the "CTK" label. Protext is a commercial service providing distribution of press releases from clients, who are identified in the text of Protext reports and who bear full responsibility for their contents.